Amifostine Prophylaxis
Amifostine Prophylaxis is a pharmacological intervention in renal protection that involves the administration of amifostine as a cytoprotective agent to selectively mitigate nephrotoxicity induced by cisplatin-based chemotherapy or radiation exposure.
17
Publications
648
Citations
81
Authors
26
Institutions
Publications per year
2017–2026
1
Parents
17
1–5 of 17
81
Uniformed Services University of the Health Sciences, United States
3 publications · 111 citations
3
h-index
Uniformed Services University of the Health Sciences, United States
3 publications · 111 citations
3
h-index
2
h-index
2
h-index
2
h-index
1–5 of 81
26
Uniformed Services University of the Health Sciences
Bethesda, United States
3 h-index
9 publications
321 citations
University of Michigan
Ann Arbor, United States
2 h-index
6 publications
86 citations
University of Arizona
Tucson, United States
2 h-index
3 publications
70 citations

University of Colorado Denver
Denver, United States
1 h-index
7 publications
119 citations
Universidade de São Paulo
São Paulo, Brazil
1 h-index
1 publications
48 citations

University of Ioannina
Ioannina, Greece
1 h-index
11 publications
220 citations
Charité - Universitätsmedizin Berlin
Berlin, Germany
1 h-index
2 publications
80 citations
Georgetown University
Washington, United States
1 h-index
4 publications
116 citations
1–8 of 26
Repository · 4 publications · 86 citations
4
h-index
2 publications · 252 citations
2
h-index
1 publications · 20 citations
1
h-index
1 publications · 15 citations
1
h-index
1 publications · 48 citations
1
h-index
1–5